Design Cloud

Image Name

News

Home page

Party group dynamics

Employee activity

2023 Self-Monitoring Public Disclosure for Shangma Park

Date:

30 Dec,2023

Self-Monitoring Report for Shangma Park, 2023

For details of the year-round public disclosure, please refer to the attachment.

Previous page

2022 Self-Monitoring Public Disclosure for Shangma Park

Good News | Wanbangde Pharmaceutical Group’s Huperzine A for Treating Myasthenia Gravis Receives U.S. FDA Orphan Drug Designation!

Next page

Related Recommendations

Image Name

2025/04/15

Good News | Warm Congratulations to Wanbande Pharmaceutical Group Co., Ltd. (Registered Trademark: wepon), which has been honored with the third batch of the "Taizhou Time-Honored Brand" title!

Image Name

2025/04/14

New peptide candidate compound: Preclinical studies in the metabolic field show promising progress.

Image Name

2025/04/14

[“Station” Success Report] | Wanbangde Pharmaceutical Group’s Postdoctoral Research Workstation Gains New Talent, Accelerating the Advancement of Innovative Drug Development!

< 1 2 3 4...78 > proceed page

Image Name

Website Development: China Enterprise Dynamics Taizhou

Business license

浙ICP备10002622号-38